Sodium-glucose cotransporter 2 inhibitors reduce new-onset heart failure and death after myocardial infarction with a preserved ejection fraction following coronary intervention. (PubMed, Am J Transl Res) - Sep 23, 2026 - "Among patients with AMI undergoing PCI and preserved LVEF, SGLT2 inhibitor use was associated with a significant reduction in new-onset HF events and improved survival outcome."
Journal • Cardiovascular • Congestive Heart Failure • Heart Failure • Myocardial Infarction • TNNI3
|
|
Aihui Zhang; Dan Li; Haitao Zhang; Hui Xu; Lingjuan Li; Suozhu Liang
|